115 related articles for article (PubMed ID: 1333105)
1. Heparin Study in Internal Medicine (HESIM): design and preliminary results.
Harenberg J; Roebruck P; Stehle G; Habscheid W; Biegholdt M; Heene DL
Thromb Res; 1992 Oct; 68(1):33-43. PubMed ID: 1333105
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group.
Harenberg J; Roebruck P; Heene DL
Haemostasis; 1996; 26(3):127-39. PubMed ID: 8738587
[TBL] [Abstract][Full Text] [Related]
3. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
4. [Prevention of venous thromboembolism in polytraumatized patients. Epidemiology and importance].
Venet C; Berger C; Tardy B; Viallon A; Decousus H; Bertrand JC
Presse Med; 2000 Jan; 29(2):68-75. PubMed ID: 10682030
[TBL] [Abstract][Full Text] [Related]
5. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients.
Harenberg J; Kallenbach B; Martin U; Dempfle CE; Zimmermann R; Kübler W; Heene DL
Thromb Res; 1990 Aug; 59(3):639-50. PubMed ID: 2173168
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
[TBL] [Abstract][Full Text] [Related]
8. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
9. Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.
Kearon C; Ginsberg JS; Julian JA; Douketis J; Solymoss S; Ockelford P; Jackson S; Turpie AG; MacKinnon B; Hirsh J; Gent M;
JAMA; 2006 Aug; 296(8):935-42. PubMed ID: 16926353
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. A comparison between unfractionated and low-molecular-weight heparin.
Faunø P; Suomalainen O; Rehnberg V; Hansen TB; Krøner K; Soimakallio S; Nielsen E
J Bone Joint Surg Am; 1994 Dec; 76(12):1814-8. PubMed ID: 7989386
[TBL] [Abstract][Full Text] [Related]
11. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery.
Birkmeyer NJ; Finks JF; Carlin AM; Chengelis DL; Krause KR; Hawasli AA; Genaw JA; English WJ; Schram JL; Birkmeyer JD;
Arch Surg; 2012 Nov; 147(11):994-8. PubMed ID: 23165612
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin.
Koller M; Schoch U; Buchmann P; Largiadèr F; von Felten A; Frick PG
Thromb Haemost; 1986 Dec; 56(3):243-6. PubMed ID: 3551180
[TBL] [Abstract][Full Text] [Related]
14. [Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials)].
Valiukiene L; Naudziūnas A; Unikauskas A
Medicina (Kaunas); 2003; 39(4):352-8. PubMed ID: 12738903
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group.
Br J Surg; 1988 Nov; 75(11):1058-63. PubMed ID: 2905187
[TBL] [Abstract][Full Text] [Related]
16. The effect of mobilisation of patients during treatment of thromboembolic disorders with low-molecular-weight heparin.
Partsch H; Kechavarz B; Köhn H; Mostbeck A
Int Angiol; 1997 Sep; 16(3):189-92. PubMed ID: 9405014
[TBL] [Abstract][Full Text] [Related]
17. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke.
Sandset PM; Dahl T; Stiris M; Rostad B; Scheel B; Abildgaard U
Semin Thromb Hemost; 1990 Oct; 16 Suppl():25-33. PubMed ID: 1962901
[TBL] [Abstract][Full Text] [Related]
18. Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy.
Macdonald RL; Amidei C; Lin G; Munshi I; Baron J; Weir BK; Brown F; Erickson RK; Hekmatpanah J
Neurosurgery; 1999 Aug; 45(2):245-51; discussion 251-2. PubMed ID: 10449068
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.
Sherman DG; Albers GW; Bladin C; Fieschi C; Gabbai AA; Kase CS; O'Riordan W; Pineo GF;
Lancet; 2007 Apr; 369(9570):1347-1355. PubMed ID: 17448820
[TBL] [Abstract][Full Text] [Related]
20. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]